Market OverviewThe Global Liposomal Doxorubicin Market is projected to witness significant growth over the next decade. Valued at USD 1.2 billion in 2023, the market is expected to reach approximately USD 2.3 billion by 2033, reflecting a compound annual growth rate (CAGR) of 6.7% from 2024 to 2033. This growth can.